Capillary electrophoresis‐mass spectrometry in impurity profiling of pharmaceutical products
- 11 April 2005
- journal article
- Published by Wiley in Electrophoresis
- Vol. 26 (7-8) , 1541-1549
- https://doi.org/10.1002/elps.200410225
Abstract
Generally reversed‐phase high‐performance liquid chromatography (RP‐HPLC) methods are extensively applied during quality control of pharmaceutical products. Since capillary electrophoresis (CE) is based on a different separation principle and consequently results in a unique selectivity compared to RP‐HPLC, it can advantageously be used as an orthogonal technique. CE equipped with a mass spectrometer detector provides even more information that can be helpful for identification and structural elucidation purposes. CE‐MS was recently implemented in the method development approach to support impurity profiling of pharmaceutical products. In this paper the application of CE‐electrospray ionization (ESI)‐MS/MS to the impurity profiling of galantamine hydrobromide in stressed Reminyl® Extended Release (ER) capsules is discussed. Reminyl® ER samples were stressed at different storing conditions. The impurity profile of these samples was compared with the current RP‐HPLC and chiral CE method, but also with CE‐ESI‐MS/MS. The combination of these three methods provided valuable data that allowed understanding comprehensively the impurity profile of these samples. Two impurities were detected at concentrations lower than 0.05%, which did not occur in nonstressed samples. Chromatographic data and the fragmentation patterns of galantamine and related compounds were also examined for identification of these two degradation products.Keywords
This publication has 12 references indexed in Scilit:
- Orthogonal separations of nicotine and nicotine‐related alkaloids by various capillary electrophoretic modesElectrophoresis, 2004
- Update on Alzheimer Drugs (Galantamine)The Neurologist, 2003
- Development and validation of a liquid chromatographic–tandem mass spectrometric method for the determination of galantamine in human heparinised plasmaJournal of Chromatography B, 2003
- Clinical experience of galantamine in dementia: a series of case reportsCurrent Medical Research and Opinion, 2003
- Clinical Pharmacokinetics of GalantamineClinical Pharmacokinetics, 2003
- Galantamine — a Novel Cholinergic Drug with a Unique Dual Mode of Action for the Treatment of Patients with Alzheimer's DiseaseCNS Drug Reviews, 2002
- Nonaqueous capillary electrophoresis-electrospray- mass spectrometry for the analysis of fluoxetine and its related compoundsElectrophoresis, 2002
- Evaluation of fourNarcissusCultivars as Potential Sources for Galanthamine ProductionPlanta Medica, 1997
- Reversed-phase liquid chromatography for the determination of galanthamine and its metabolites in human plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- High-performance liquid chromatographic determination of galanthamine, a long-acting anticholinesterase drug, in serum, urine and bileJournal of Chromatography B: Biomedical Sciences and Applications, 1982